Look Out McDonald's And KFC: Here Comes China's Alan Song

Look Out McDonald's And KFC: Here Comes China's Alan Song

HONG KONG, March 4, 2025 /PRNewswire/ -- China's largest restaurant chains aren't as well-known globally as McDonald's and KFC. Yet one of the country's most successful venture capitalists thinks their international heft will increase over time,...

XCMG's Three Factories Recognized in China's 2024 National Green Factory List

XCMG's Three Factories Recognized in China's 2024 National Green Factory List

XUZHOU, China, March 3, 2025 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE: 000425), a leading global construction machinery manufacturer, has proudly announced that three of its factories, specialized for road machinery, firefighting equipment and...

Dongying's investment soars with quality focus

Dongying's investment soars with quality focus

DONGYING, China, Feb. 21, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn: Dongying's investment promotion system has made significant strides in 2024 by enhancing the quality and efficiency of investment attraction. The city has seen a...

Coway Announces Financial Results for Q4 and FY2024

Coway Announces Financial Results for Q4 and FY2024

Coway's 2024 Q4 revenue reached KRW 1,125.7 billion (+12.1% YoY) with an operating profit amounted to KRW 183.4 billion (+10.4% YoY) The company's FY2024 annual revenue totaled KRW 4,310.1 billion (+8.7% YoY) with an operating profit of KRW 795.4...

Shaping Tomorrow's Cities: Lee Kuan Yew Global Business Plan Competition Launches Global Hunt for Sustainable Urban Innovations

Shaping Tomorrow's Cities: Lee Kuan Yew Global Business Plan Competition Launches Global Hunt for Sustainable Urban Innovations

SINGAPORE, Jan. 21, 2025 /PRNewswire/ -- Singapore Management University's (SMU) Institute of Innovation and Entrepreneurship (IIE) announced today the opening of applications for the 12th edition of its flagship event - the Lee Kuan Yew Global...

O-RAN ALLIANCE Summit at MWC Barcelona 2025 To Focus on Expanding O-RAN Adoption and Future Outlook

O-RAN ALLIANCE Summit at MWC Barcelona 2025 To Focus on Expanding O-RAN Adoption and Future Outlook

O-RAN ALLIANCE Summit to take place on Tuesday 4 March 2025, 8:30-13:00 CET in MWC Barcelona Hall 8, Theatre 6, with free online broadcast The Summit will provide a comprehensive update on the state of O-RAN, insights on operational experience,...

Leadership change fuels Busways' strategic ambitions

Leadership change fuels Busways' strategic ambitions

SYDNEY, Jan. 15, 2025 /PRNewswire/ -- Busways, the largest Australian-owned bus operator, has appointed Will O'Neill as its new Chief Executive Officer, effective January 1, 2025. Byron Rowe and Will O' Neill Mr O'Neill steps up to the helm after a...

Morphy Richards Expands Global Footprint: New Distributors and Innovative Portable Air Conditioner Launch in 2024

Morphy Richards Expands Global Footprint: New Distributors and Innovative Portable Air Conditioner Launch in 2024

LONDON, Jan. 7, 2025 /PRNewswire/ -- In 2024, Morphy Richards embarked on a significant transformation, prioritizing the creation of innovative products that enhance everyday life. A standout achievement this year was the launch of the world's first...

CIFF Guangzhou 2025 Preview: A Focus on Creative Design and Trade Upgrades

CIFF Guangzhou 2025 Preview: A Focus on Creative Design and Trade Upgrades

GUANGZHOU, China, Jan. 7, 2025 /PRNewswire/ -- The first phase of the 55th edition of the China International Furniture Fair (Guangzhou) (CIFF Guangzhou 2025), featuring Home Furniture, is set to take place from March 18 to 21, 2025, at the Canton...

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization The Company has completed enrollment of a dose escalation study of givastomig in combination with...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • menu
    menu